You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

allogenic NK cells

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Xuzhou (allogenic NK cells)

Recruiting
  • Acute Myeloid Leukemia
  • allogenic NK cells
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Feb 23, 2023

Acute Lymphoblastic Leukemia, B-cell Lymphoma, Chronic Lymphocytic Leukemia Trial in Xuzhou (allogenic CD19-CAR-NK cells)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • allogenic CD19-CAR-NK cells
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Feb 11, 2023

Anatomic Stage IV Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma Trial in Columbus (procedure, drug, biological)

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • HER2-Negative Breast Carcinoma
  • Biospecimen Collection
  • +5 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Aug 30, 2023

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia Recurrent Trial in Beijing (CD123-CAR-NK cells)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Acute Myeloid Leukemia Recurrent
  • CD123-CAR-NK cells
  • Beijing, Beijing, China
    The Fifth Medical Center of Chinese People's Liberation Army (PL
Oct 24, 2022

Allogenic Stem Cell Transplantation Trial (SAR445419)

Not yet recruiting
  • Allogenic Stem Cell Transplantation
  • (no location specified)
Feb 13, 2023

Breast Tumors Trial in Barcelona (Cyclophosphamide, Trastuzumab, Pertuzumab)

Recruiting
  • Breast Neoplasms
  • Barcelona, Spain
  • +1 more
May 31, 2022

Heart Failure, Systolic Trial (CardiALLO™ Human Allogenic Culture-expanded Bone marrow-derived Mesenchymal Stem Cells (hMSCs))

Not yet recruiting
  • Heart Failure, Systolic
  • CardiALLO™ Human Allogenic Culture-expanded Bone marrow-derived Mesenchymal Stem Cells (hMSCs)
  • (no location specified)
Jun 22, 2023

Multiple Myeloma, Plasma Cell Leukemia Trial in Shanghai (Human BCMA targeted CAR-NK cells injection)

Recruiting
  • Multiple Myeloma
  • Plasma Cell Leukemia
  • Human BCMA targeted CAR-NK cells injection
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Sep 13, 2023

Advanced Melanoma, Metastatic Melanoma Trial in Saint Louis (Memory-like natural killer cells, Relatilmab, Nivolumab)

Not yet recruiting
  • Advanced Melanoma
  • Metastatic Melanoma
  • Memory-like natural killer cells
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 16, 2022

Adult Relapsed/Refractory B-cell Hematologic Malignancies Trial in Beijing (CD19-CAR-NK)

Recruiting
  • Adult Relapsed/Refractory B-cell Hematologic Malignancies
  • CD19-CAR-NK
  • Beijing, Beijing, China
    The Fifth Medical Center of Chinese People's Liberation Army (PL
Dec 1, 2022

Diffuse Large B Cell Lymphoma Trial (anti-CD19 CAR NK cells)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • anti-CD19 CAR NK cells
  • (no location specified)
Dec 21, 2022

EBV Infection After Allogenic HSCT Trial in Beijing (EBV-TCR-T cells)

Recruiting
  • EBV Infection After Allogenic HSCT
  • EBV-TCR-T cells
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Nov 3, 2023

Knee Osteoarthritis Trial (Allogenic adipose derived mesenchymal stem cells (AD-MSC), Saline)

Not yet recruiting
  • Knee Osteoarthritis
  • Allogenic adipose derived mesenchymal stem cells (AD-MSC)
  • Saline
  • (no location specified)
Jun 26, 2023

Acute Myeloid Leukemia Trial in Houston (Azacitidine, Venetoclax, NK Cells)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    M.D. Anderson Cancer Center
Apr 17, 2023

Solid Tumors Trial in Houston (Rimiducid, TROP2-CAR-NK Cells, Fludarabine phosphate)

Not yet recruiting
  • Solid Tumors
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2023

Pediatric Brain Tumor, Recurrent Pediatric Brain Tumor, Pediatric Supratentorial Tumor Trial in San Francisco (Universal Donor

Not yet recruiting
  • Pediatric Brain Tumor
  • +2 more
  • Universal Donor (UD) Transforming growth factor beta imprinting (TGFβi) Natural Killer (NK) Cells
  • Implantation
  • San Francisco, California
    University of California, San Francisco
May 24, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Leukemia Trial in Boston (Cytokine-Induced Memory-like Natural Killer

Not yet recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Cytokine-Induced Memory-like Natural Killer Cells
  • +2 more
  • Boston, Massachusetts
  • +1 more
Nov 22, 2023

Myeloma Trial in Houston (Fludarabine phosphate, Cyclophosphamide, NY-ESO-1 TCR/IL-15 NK)

Not yet recruiting
  • Myeloma
  • Fludarabine phosphate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2023

Malignant Sarcoma Trial in Madrid (Natural Killer (NK) cells (a new immunotherapy))

Recruiting
  • Malignant Sarcoma
  • Natural Killer (NK) cells (a new immunotherapy)
  • Madrid, Spain
    Hospital Universitario La Paz
Jul 19, 2023

Systemic Lupus Erythematosus (SLE) Trial in Shanghai (anti-CD19 CAR NK cells (KN5501))

Recruiting
  • Systemic Lupus Erythematosus (SLE)
  • anti-CD19 CAR NK cells (KN5501)
  • Shanghai, China
    Changhai Hospital
Aug 25, 2023

Knee Osteoarthritis Trial in Shanghai, Beijing, Hangzhou (Mesenchymal progenitor cells, Sodium Hyaluronate Injection)

Not yet recruiting
  • Knee Osteoarthritis
  • Mesenchymal progenitor cells
  • Sodium Hyaluronate Injection
  • Shanghai, Shanghai, China
  • +5 more
Aug 9, 2023

B-Cell Lymphoblastic Leukemia/Lymphoma Trial in Kunming (Anti-CD19 UCAR-NK cells)

Recruiting
  • B-Cell Lymphoblastic Leukemia/Lymphoma
  • Anti-CD19 UCAR-NK cells
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
Dec 19, 2022

Acute Myeloid Leukemia Trial in Cincinnati (CIML-NK Cells)

Recruiting
  • Acute Myeloid Leukemia
  • CIML-NK Cells
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Jan 4, 2023

Chronic Myeloid Leukemia (CML), Pancreatic Ca, Colon/Rectal Ca Trial run by the National Heart, Lung, and Blood Institute

Completed
  • Chronic Myeloid Leukemia (CML)
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 31, 2022

AML, Adult Trial in Hangzhou (CLL1 CAR-NK cell injection)

Recruiting
  • AML, Adult
  • CLL1 CAR-NK cell injection
  • Hangzhou, Zhejiang, China
    Clinical research ethics committee of the first affiliated hospi
Aug 30, 2023